AMGN vs QURE · P/E 24, rev $10.05B vs rev $16.1M
Amgen Inc (AMGN) versus Uniqure NV (QURE) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. QURE currently screens at market cap $3.04B.
Not investment advice. Open the AMGN and QURE stock pages for the full models.
Not investment advice.